Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN – Get Free Report) was the target of a large growth in short interest in December. As of December 31st, there was short interest totalling 473,700 shares, a growth of 69.2% from the December 15th total of 279,900 shares. Currently, 2.8% of the company’s shares are sold short. Based on an average daily volume of 582,700 shares, the days-to-cover ratio is currently 0.8 days.
Inspira Technologies Oxy B.H.N. Trading Up 0.9 %
Shares of IINN traded up $0.01 during trading hours on Friday, reaching $1.07. 318,035 shares of the company traded hands, compared to its average volume of 2,961,752. Inspira Technologies Oxy B.H.N. has a 12 month low of $0.80 and a 12 month high of $2.45. The company has a current ratio of 2.23, a quick ratio of 2.13 and a debt-to-equity ratio of 0.09. The company’s fifty day moving average price is $1.18 and its two-hundred day moving average price is $1.20.
Institutional Trading of Inspira Technologies Oxy B.H.N.
A hedge fund recently bought a new stake in Inspira Technologies Oxy B.H.N. stock. Renaissance Technologies LLC purchased a new position in Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN – Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 24,497 shares of the company’s stock, valued at approximately $34,000. Renaissance Technologies LLC owned 0.19% of Inspira Technologies Oxy B.H.N. as of its most recent SEC filing. Hedge funds and other institutional investors own 12.72% of the company’s stock.
About Inspira Technologies Oxy B.H.N.
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.
Featured Stories
- Five stocks we like better than Inspira Technologies Oxy B.H.N.
- How to Invest in Blue Chip Stocks
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- 5 discounted opportunities for dividend growth investors
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- Top Biotech Stocks: Exploring Innovation Opportunities
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Inspira Technologies Oxy B.H.N. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspira Technologies Oxy B.H.N. and related companies with MarketBeat.com's FREE daily email newsletter.